Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets
Confo Therapeutics has raised €30M in a Series A round that will take its unique…
07/05/2019 - 3 minutes
Confo Therapeutics
Belgian Biotech and Roche Take on Neurological and Developmental Disorders
Confo Therapeutics has joined forces with Roche to develop new small molecule agonists of a…
19/12/2017 - 2 minutes
Belgian Biotech Teams Up With Lundbeck to Collaborate on Drug Discovery
Confo and Lundbeck have joined forces to push through drug discovery against a tough-to-target protein…
26/09/2017 - 2 minutes
A Painful Case: How Biotech is trying to Break Through in Analgesia
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great,…
06/06/2017 - 7 minutes
Young Belgian Biotech will tackle Fibrosis with a New Grant
Confo Therapeutics has received a €1.6M grant to support the discovery of drugs against fibrosis,…
01/02/2017 - 2 minutes
These Biotech Veterans have Launched a Startup to ‘Drug the Undruggable’
GPCRs have spelled “dead end” for many a biotech and academic endeavor. I sat down…
23/11/2016 - 4 minutes
